{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:01:30Z","timestamp":1784642490274,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Z23C050004"],"award-info":[{"award-number":["Z23C050004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81722044, 91753115, 21778049, 81861148018"],"award-info":[{"award-number":["81722044, 91753115, 21778049, 81861148018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73412-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:45:53Z","timestamp":1779684353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular mechanisms for subtype selectivity of kinin receptors\u2019 antagonists"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8476-3252","authenticated-orcid":false,"given":"Meng","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1207-5312","authenticated-orcid":false,"given":"Aleksey","family":"Raskovalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-9378","authenticated-orcid":false,"given":"My V. T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiliu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-3397","authenticated-orcid":false,"given":"Donggyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayden","family":"Salve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-4505","authenticated-orcid":false,"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-3914","authenticated-orcid":false,"given":"Vadim","family":"Cherezov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-2951","authenticated-orcid":false,"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"73412_CR1","first-page":"124","volume":"11","author":"C Golias","year":"2007","unstructured":"Golias, C., Charalabopoulos, A., Stagikas, D., Charalabopoulos, K. & Batistatou, A. The kinin system - bradykinin: biological effects and clinical implications. Multiple role of the kinin system\u2014bradykinin. Hippokratia 11, 124\u2013128 (2007).","journal-title":"Hippokratia"},{"key":"73412_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0014-2999(01)01318-8","volume":"429","author":"R Couture","year":"2001","unstructured":"Couture, R., Harrisson, M., Vianna, R. M. & Cloutier, F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429, 161\u2013176 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"73412_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.autrev.2016.12.011","volume":"16","author":"RC Dutra","year":"2017","unstructured":"Dutra, R. C. Kinin receptors: key regulators of autoimmunity. Autoimmun. Rev. 16, 192\u2013207 (2017).","journal-title":"Autoimmun. Rev."},{"key":"73412_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/1354750X.2013.787544","volume":"18","author":"E Kashuba","year":"2013","unstructured":"Kashuba, E., Bailey, J., Allsup, D. & Cawkwell, L. The kinin\u2013kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers. Biomarkers 18, 279\u2013296 (2013).","journal-title":"Biomarkers"},{"key":"73412_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/ddc2030028","volume":"2","author":"F Marceau","year":"2023","unstructured":"Marceau, F. Drugs of the kallikrein\u2013kinin system: an overview. Drugs Drug Candidates 2, 538\u2013553 (2023).","journal-title":"Drugs Drug Candidates"},{"key":"73412_CR6","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.2147\/JIR.S488237","volume":"17","author":"M Ji","year":"2024","unstructured":"Ji, M., Ran, X., Zuo, H. & Zhang, Q. Novel insights into the kallikrein\u2013kinin system in fulminant myocarditis: physiological basis and potential therapeutic advances. JIR 17, 7347\u20137360 (2024).","journal-title":"JIR"},{"key":"73412_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/prot.20768","volume":"62","author":"J-S Surgand","year":"2006","unstructured":"Surgand, J.-S., Rodrigo, J., Kellenberger, E. & Rognan, D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins: Struct., Funct., Bioinforma. 62, 509\u2013538 (2006).","journal-title":"Proteins: Struct., Funct., Bioinforma."},{"key":"73412_CR8","doi-asserted-by":"publisher","first-page":"104715","DOI":"10.1016\/j.phrs.2020.104715","volume":"155","author":"S Sriramula","year":"2020","unstructured":"Sriramula, S. Kinin B1 receptor: a target for neuroinflammation in hypertension. Pharmacol. Res. 155, 104715 (2020).","journal-title":"Pharmacol. Res."},{"key":"73412_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1439-0272.2003.00533.x","volume":"35","author":"A Blaukat","year":"2003","unstructured":"Blaukat, A. Structure and signalling pathways of kinin receptors. Andrologia 35, 17\u201323 (2003).","journal-title":"Andrologia"},{"key":"73412_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.57.1.2","volume":"57","author":"LMF Leeb-Lundberg","year":"2005","unstructured":"Leeb-Lundberg, L. M. F., Marceau, F., M\u00fcller-Esterl, W., Pettibone, D. J. & Zuraw, B. L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharm. Rev. 57, 27\u201377 (2005).","journal-title":"Pharm. Rev."},{"key":"73412_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/ph13080199","volume":"13","author":"J Lau","year":"2020","unstructured":"Lau, J., Rousseau, J., Kwon, D., B\u00e9nard, F. & Lin, K.-S. A systematic review of molecular imaging agents targeting bradykinin B1 and B2 receptors. Pharmaceuticals 13, 199 (2020).","journal-title":"Pharmaceuticals"},{"key":"73412_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2013.12.009","volume":"345","author":"PLN Da Costa","year":"2014","unstructured":"Da Costa, P. L. N., Sirois, P., Tannock, I. F. & Chammas, R. The role of kinin receptors in cancer and therapeutic opportunities. Cancer Lett. 345, 27\u201338 (2014).","journal-title":"Cancer Lett."},{"key":"73412_CR13","doi-asserted-by":"publisher","first-page":"9915","DOI":"10.1007\/s11033-022-07539-2","volume":"49","author":"DAB Rex","year":"2022","unstructured":"Rex, D. A. B., Vaid, N., Deepak, K., Dagamajalu, S. & Prasad, T. S. K. A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases. Mol. Biol. Rep. 49, 9915\u20139927 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"73412_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.peptides.2003.10.016","volume":"25","author":"JM Stewart","year":"2004","unstructured":"Stewart, J. M. Bradykinin antagonists: discovery and development. Peptides 25, 527\u2013532 (2004).","journal-title":"Peptides"},{"key":"73412_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1522","volume":"3","author":"F Marceau","year":"2004","unstructured":"Marceau, F. & Regoli, D. Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3, 845\u2013852 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73412_CR16","doi-asserted-by":"publisher","first-page":"106305","DOI":"10.1016\/j.intimp.2020.106305","volume":"82","author":"F Marceau","year":"2020","unstructured":"Marceau, F. et al. Bradykinin receptors: agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int. Immunopharmacol. 82, 106305 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"73412_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi, M. et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N. Engl. J. Med 363, 532\u2013541 (2010).","journal-title":"N. Engl. J. Med"},{"key":"73412_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12967-024-05216-5","volume":"22","author":"P Wisniewski","year":"2024","unstructured":"Wisniewski, P., Gangnus, T. & Burckhardt, B. B. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system. J. Transl. Med 22, 388 (2024).","journal-title":"J. Transl. Med"},{"key":"73412_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41401-022-00982-8","volume":"44","author":"J Shen","year":"2023","unstructured":"Shen, J. & Zhang, H. Function and structure of bradykinin receptor 2 for drug discovery. Acta Pharm. Sin. 44, 489\u2013498 (2023).","journal-title":"Acta Pharm. Sin."},{"key":"73412_CR20","doi-asserted-by":"publisher","unstructured":"Marceau, F., Charest-Morin, X. & Gera, L. Chapter 5 - Peptide and nonpeptide ligands acting at bradykinin receptors. in Bradykinin (ed. Couture, R.) 139\u2013164 (Academic Press, 2025). https:\/\/doi.org\/10.1016\/B978-0-443-28907-1.00004-9.","DOI":"10.1016\/B978-0-443-28907-1.00004-9"},{"key":"73412_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28399-1","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen, J. et al. Cryo-EM structures of human bradykinin receptor-Gq proteins complexes. Nat. Commun. 13, 714 (2022).","journal-title":"Nat. Commun."},{"key":"73412_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41594-021-00645-y","volume":"28","author":"Y-L Yin","year":"2021","unstructured":"Yin, Y.-L. et al. Molecular basis for kinin selectivity and activation of the human bradykinin receptors. Nat. Struct. Mol. Biol. 28, 755\u2013761 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"73412_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.107.120352","volume":"322","author":"JE Hawkinson","year":"2007","unstructured":"Hawkinson, J. E. et al. Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958.  J. Pharmacol. Exp. Therapeutics 322, 619\u2013630 (2007).","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"73412_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.peptides.2003.06.003","volume":"24","author":"BH Gabra","year":"2003","unstructured":"Gabra, B. H. & Sirois, P. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides 24, 1131\u20131139 (2003).","journal-title":"Peptides"},{"key":"73412_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1139\/y95-109","volume":"73","author":"DG Sawutz","year":"1995","unstructured":"Sawutz, D. G., Salvino, J. M., Dolle, R. E., Seoane, P. R. & Farmer, S. G. Pharmacology and structure \u2013 activity relationships of the nonpeptide bradykinin receptor antagonist WIN 64338. Can. J. Physiol. Pharmacol. 73, 805\u2013811 (1995).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"73412_CR26","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41594-022-00859-8","volume":"29","author":"MJ Robertson","year":"2022","unstructured":"Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. 29, 1188\u20131195 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"73412_CR27","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. in Methods in Neurosciences vol. 25 366\u2013428 (Elsevier, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"73412_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nature20606","volume":"540","author":"C Oswald","year":"2016","unstructured":"Oswald, C. et al. Intracellular allosteric antagonism of the CCR9 receptor. Nature 540, 462\u2013465 (2016).","journal-title":"Nature"},{"key":"73412_CR29","doi-asserted-by":"publisher","first-page":"e202115545","DOI":"10.1002\/anie.202115545","volume":"61","author":"T Claff","year":"2022","unstructured":"Claff, T. et al. Single stabilizing point mutation enables high-resolution co-crystal structures of the adenosine A2A receptor with preladenant conjugates. Angew. Chem. Int. Ed. 61, e202115545 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"73412_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jmb.2007.12.028","volume":"376","author":"CB Roth","year":"2008","unstructured":"Roth, C. B., Hanson, M. A. & Stevens, R. C. Stabilization of the \u03b22-adrenergic receptor 4-3-5 helix interface by mutagenesis of Glu-1223.41, a critical residue in GPCR structure. J. Mol. Biol. 376, 1305\u20131319 (2008).","journal-title":"J. Mol. Biol."},{"key":"73412_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1124\/jpet.103.059527","volume":"309","author":"J Gougat","year":"2004","unstructured":"Gougat, J. et al. SSR240612 [(2 R)-2-[((3 R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.  J. Pharmacol. Exp. Ther. 309, 661\u2013669 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73412_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/jpet.105.098368","volume":"318","author":"F Porreca","year":"2006","unstructured":"Porreca, F. et al. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist. J. Pharmacol. Exp. Ther. 318, 195\u2013205 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73412_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/jm061094b","volume":"50","author":"SD Kuduk","year":"2007","unstructured":"Kuduk, S. D. et al. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists. J. Med. Chem. 50, 272\u2013282 (2007).","journal-title":"J. Med. Chem."},{"key":"73412_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/01.HYP.28.5.833","volume":"28","author":"F Gobeil","year":"1996","unstructured":"Gobeil, F. et al. Structure-activity studies of B1 receptor\u2013related peptides: antagonists. Hypertension 28, 833\u2013839 (1996).","journal-title":"Hypertension"},{"key":"73412_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1139\/y02-053","volume":"80","author":"W Neugebauer","year":"2002","unstructured":"Neugebauer, W. et al. Kinin B1 receptor antagonists with multi-enzymatic resistance properties. Can. J. Physiol. Pharmacol. 80, 287\u2013292 (2002).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"73412_CR36","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1073\/pnas.91.11.4693","volume":"91","author":"DG Sawutz","year":"1994","unstructured":"Sawutz, D. G. et al. The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91, 4693\u20134697 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"73412_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0162-3109(99)00128-9","volume":"43","author":"D Pruneau","year":"1999","unstructured":"Pruneau, D. et al. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology 43, 187\u2013194 (1999).","journal-title":"Immunopharmacology"},{"key":"73412_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejphar.2005.10.014","volume":"528","author":"P Cucchi","year":"2005","unstructured":"Cucchi, P. et al. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. Eur. J. Pharmacol. 528, 7\u201316 (2005).","journal-title":"Eur. J. Pharmacol."},{"key":"73412_CR39","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3389\/fphar.2020.00916","volume":"11","author":"A Lesage","year":"2020","unstructured":"Lesage, A. et al. In vitro pharmacological profile of a new small molecule bradykinin B2 receptor antagonist. Front. Pharmacol. 11, 916 (2020).","journal-title":"Front. Pharmacol."},{"key":"73412_CR40","doi-asserted-by":"publisher","first-page":"41100","DOI":"10.1074\/jbc.M104875200","volume":"276","author":"J Marie","year":"2001","unstructured":"Marie, J. et al. Control of conformational equilibria in the human B2 bradykinin receptor. J. Biol. Chem. 276, 41100\u201341111 (2001).","journal-title":"J. Biol. Chem."},{"key":"73412_CR41","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1476-5381.2010.01133.x","volume":"162","author":"S Meini","year":"2011","unstructured":"Meini, S. et al. Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor. Br. J. Pharmacol. 162, 1202\u20131212 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"73412_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1139\/y02-027","volume":"80","author":"S Meini","year":"2002","unstructured":"Meini, S. et al. Preliminary mutational analysis of the human kinin B2 receptor for nonpeptide antagonist ligands recognition. Can. J. Physiol. Pharm. 80, 303\u2013309 (2002).","journal-title":"Can. J. Physiol. Pharm."},{"key":"73412_CR43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","volume":"161","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Structure of the angiotensin receptor revealed by serial femtosecond crystallography. Cell 161, 833\u2013844 (2015).","journal-title":"Cell"},{"key":"73412_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature22035","volume":"544","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Structural basis for selectivity and diversity in angiotensin II receptors. Nature 544, 327\u2013332 (2017).","journal-title":"Nature"},{"key":"73412_CR45","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.aay9813","volume":"367","author":"LM Wingler","year":"2020","unstructured":"Wingler, L. M. et al. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR. Science 367, 888\u2013892 (2020).","journal-title":"Science"},{"key":"73412_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.str.2019.12.003","volume":"28","author":"H Asada","year":"2020","unstructured":"Asada, H. et al. The crystal structure of angiotensin II type 2 receptor with endogenous peptide hormone. Structure 28, 418\u2013425.e4 (2020).","journal-title":"Structure"},{"key":"73412_CR47","doi-asserted-by":"publisher","unstructured":"Zhang, D. et al. Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists. EMBO J. 42, e112940 https:\/\/doi.org\/10.15252\/embj.2022112940 (2023).","DOI":"10.15252\/embj.2022112940"},{"key":"73412_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1367-5931(00)00107-1","volume":"4","author":"MG Bock","year":"2000","unstructured":"Bock, M. G. & Longmore, J. Bradykinin antagonists: new opportunities. Curr. Opin. Chem. Biol. 4, 401\u2013406 (2000).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"73412_CR49","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1398-9995.2011.02686.x","volume":"66","author":"M Maurer","year":"2011","unstructured":"Maurer, M. et al. New topics in bradykinin research. Allergy 66, 1397\u20131406 (2011).","journal-title":"Allergy"},{"key":"73412_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41467-020-14889-7","volume":"11","author":"T Che","year":"2020","unstructured":"Che, T. et al. Nanobody-enabled monitoring of kappa opioid receptor states. Nat. Commun. 11, 1145 (2020).","journal-title":"Nat. Commun."},{"key":"73412_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","volume":"172","author":"T Che","year":"2018","unstructured":"Che, T. et al. Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell 172, 55\u201367.e15 (2018).","journal-title":"Cell"},{"key":"73412_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"73412_CR53","doi-asserted-by":"publisher","first-page":"e83724","DOI":"10.7554\/eLife.83724","volume":"11","author":"J Zivanov","year":"2022","unstructured":"Zivanov, J. et al. A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0. eLife 11, e83724 (2022).","journal-title":"eLife"},{"key":"73412_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"73412_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"73412_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"73412_CR57","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"73412_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"73412_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"73412_CR60","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2024.01.028","volume":"187","author":"R Janicot","year":"2024","unstructured":"Janicot, R. et al. Direct interrogation of context-dependent GPCR activity with a universal biosensor platform. Cell 187, 1527\u20131546.e25 (2024).","journal-title":"Cell"},{"key":"73412_CR61","doi-asserted-by":"publisher","first-page":"103355","DOI":"10.1016\/j.xpro.2024.103355","volume":"5","author":"R Janicot","year":"2024","unstructured":"Janicot, R. & Garcia-Marcos, M. Protocol for detecting endogenous GPCR activity in primary cell cultures using ONE-GO biosensors. STAR Protoc. 5, 103355 (2024).","journal-title":"STAR Protoc."},{"key":"73412_CR62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41422-024-00966-9","volume":"34","author":"A Raskovalov","year":"2024","unstructured":"Raskovalov, A., Kim, D. & Cherezov, V. ONE-GO: direct detection of context-dependent GPCR activity. Cell Res. 34, 543\u2013544 (2024).","journal-title":"Cell Res."},{"key":"73412_CR63","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jcc.540150503","volume":"15","author":"R Abagyan","year":"1994","unstructured":"Abagyan, R., Totrov, M. & Kuznetsov, D. ICM\u2014a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15, 488\u2013506 (1994).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73412-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:06:03Z","timestamp":1784639163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73412"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73412-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6783"}}